ASX - By Stock
|
EMD |
Re:
general talk
|
|
OldPapaSmurf
|
379 |
139K |
1 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
379
|
139K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Eminent Healthcare Leader New Independent Non-Exec Chair
|
|
OldPapaSmurf
|
3 |
1.9K |
6 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
3
|
1.9K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Health Canada Approval Received for MDMA Import
|
|
OldPapaSmurf
|
7 |
2.3K |
4 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
7
|
2.3K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Change of Director's Interest Notice - S. Washer
|
|
OldPapaSmurf
|
3 |
1.0K |
6 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
3
|
1.0K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria Recruits First Patient MDMA-Assisted Therapy Trial
|
|
OldPapaSmurf
|
31 |
11K |
2 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
31
|
11K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
OldPapaSmurf
|
25 |
8.3K |
0 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
25
|
8.3K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
OldPapaSmurf
|
25 |
8.3K |
3 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
25
|
8.3K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
OldPapaSmurf
|
25 |
8.3K |
8 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
25
|
8.3K
|
8
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
OldPapaSmurf
|
25 |
8.3K |
8 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
25
|
8.3K
|
8
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
OldPapaSmurf
|
25 |
8.3K |
1 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
25
|
8.3K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
OldPapaSmurf
|
379 |
139K |
12 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
379
|
139K
|
12
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
OldPapaSmurf
|
379 |
139K |
0 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
379
|
139K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Strong Recruitment for EMD-RX5 Phase 3 Trial
|
|
OldPapaSmurf
|
17 |
6.4K |
4 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
17
|
6.4K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
News: EMD Emyria Receives firm Commitments In A Well Supported A$2.5M Placement
|
|
OldPapaSmurf
|
72 |
23K |
3 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
72
|
23K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria Unveils Highest Potency CBD Capsule for FDA Pathway
|
|
OldPapaSmurf
|
8 |
2.8K |
4 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
8
|
2.8K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Strong Recruitment for EMD-RX5 Phase 3 Trial
|
|
OldPapaSmurf
|
17 |
6.4K |
6 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
17
|
6.4K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria secures clinical-grade MDMA supply for Aust patients
|
|
OldPapaSmurf
|
57 |
16K |
10 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
57
|
16K
|
10
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
OldPapaSmurf
|
125 |
34K |
13 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
125
|
34K
|
13
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
OldPapaSmurf
|
125 |
34K |
6 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
125
|
34K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
OldPapaSmurf
|
125 |
34K |
5 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
125
|
34K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria expands MDMA programs following landmark TGA decision
|
|
OldPapaSmurf
|
7 |
3.4K |
11 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
7
|
3.4K
|
11
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
OldPapaSmurf
|
125 |
34K |
10 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
125
|
34K
|
10
|
|
ASX - By Stock
|
EMD |
Re:
Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial
|
|
OldPapaSmurf
|
21 |
6.2K |
0 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
21
|
6.2K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial
|
|
OldPapaSmurf
|
21 |
6.2K |
9 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
21
|
6.2K
|
9
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Biotech Showcase San Francisco Presentation
|
|
OldPapaSmurf
|
31 |
8.5K |
1 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
31
|
8.5K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria and UWA expand unique MDMA-inspired analogue library
|
|
OldPapaSmurf
|
39 |
10K |
2 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
39
|
10K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Nasodine Composition Patent Accepted in Australia
|
|
OldPapaSmurf
|
7 |
2.6K |
0 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
7
|
2.6K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Chart - EMD
|
|
OldPapaSmurf
|
90 |
26K |
4 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
90
|
26K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Chart - EMD
|
|
OldPapaSmurf
|
90 |
26K |
0 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
90
|
26K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick announces formation of Scientific Advisory Board
|
|
OldPapaSmurf
|
1 |
812 |
3 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
1
|
812
|
3
|
|
ASX - By Stock
|
EMD |
Re:
EMD value by the end of the June 2023?
|
|
OldPapaSmurf
|
33 |
9.3K |
7 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
33
|
9.3K
|
7
|
|
ASX - By Stock
|
EMD |
Re:
EMD value by the end of the June 2023?
|
|
OldPapaSmurf
|
33 |
9.3K |
6 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
33
|
9.3K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
EMD value by the end of the June 2023?
|
|
OldPapaSmurf
|
33 |
9.3K |
4 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
33
|
9.3K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
EMD value by the end of the June 2023?
|
|
OldPapaSmurf
|
33 |
9.3K |
1 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
33
|
9.3K
|
1
|
|
ASX - By Stock
|
EMD |
EMD value by the end of the June 2023?
|
|
OldPapaSmurf
|
33 |
9.3K |
2 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
33
|
9.3K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
OldPapaSmurf
|
45 |
9.6K |
4 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
45
|
9.6K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
OldPapaSmurf
|
45 |
9.6K |
2 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
45
|
9.6K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
OldPapaSmurf
|
45 |
9.6K |
0 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
45
|
9.6K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
OldPapaSmurf
|
45 |
9.6K |
5 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
45
|
9.6K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
|
|
OldPapaSmurf
|
21 |
5.4K |
4 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
21
|
5.4K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
|
|
OldPapaSmurf
|
21 |
5.4K |
8 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
21
|
5.4K
|
8
|
|
ASX - By Stock
|
SZL |
Re:
SZL TO by Affirm
|
|
OldPapaSmurf
|
123 |
55K |
1 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
123
|
55K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Preclinical studies initiated for MDMA-inspired analogues
|
|
OldPapaSmurf
|
22 |
5.5K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
22
|
5.5K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria expands drug candidate library inspired by MDMA
|
|
OldPapaSmurf
|
9 |
3.3K |
8 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
9
|
3.3K
|
8
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
OldPapaSmurf
|
94 |
29K |
0 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
94
|
29K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
FRE is one to watch
|
|
OldPapaSmurf
|
126 |
47K |
0 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
126
|
47K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
OldPapaSmurf
|
379 |
139K |
0 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
379
|
139K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
OldPapaSmurf
|
379 |
139K |
0 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
379
|
139K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
OldPapaSmurf
|
94 |
29K |
7 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
94
|
29K
|
7
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria expands MDMA analogue program with UWA
|
|
OldPapaSmurf
|
5 |
2.5K |
1 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
5
|
2.5K
|
1
|
|